Cellmid: Revenue Stage ASX Biotech with Strong Drug Pipeline

Apr. 6, 2016
Dave Gentry, host of "The RedChip Money Report", interviews Maria Halasz, CEO of Cellmid (ASX: CDY). Cellmid Limited develops and commercializes ...

 Read More

Bloomberg TV Show

CEO Interviews

"I work with many of the companies that would be RedChip companies. And we certainly ascribe to the same view that the RedChip Companies do, which is Discovering Tomorrow's Blue Chips Today."

  • Bob McCooey, Senior Vice President, NASDAQ Stock Market